Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 2
2012 2
2013 1
2015 1
2016 2
2017 4
2019 3
2020 4
2021 6
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine response in people with multiple sclerosis treated with fumarates.
Tremblay MA, Vukusic S, Shanmugasundaram M, Bozin I, Levin S, Gocke A, Wipfler P. Tremblay MA, et al. Among authors: wipfler p. Mult Scler J Exp Transl Clin. 2023 Sep 6;9(3):20552173231191170. doi: 10.1177/20552173231191170. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37692293 Free PMC article. Review.
Impact of vaccination on COVID-19 outcome in multiple sclerosis.
Bsteh G, Gradl C, Heschl B, Hegen H, Di Pauli F, Assar H, Leutmezer F, Traxler G, Krajnc N, Zulehner G, Hiller MS, Rommer P, Wipfler P, Guger M, Enzinger C, Berger T; AUT-MuSC investigators. Bsteh G, et al. Among authors: wipfler p. Eur J Neurol. 2022 Jul 5:10.1111/ene.15488. doi: 10.1111/ene.15488. Online ahead of print. Eur J Neurol. 2022. PMID: 35791496 Free PMC article.
Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.
Bsteh G, Assar H, Gradl C, Heschl B, Hiller MS, Krajnc N, Di Pauli F, Hegen H, Traxler G, Leutmezer F, Wipfler P, Zulehner G, Guger M, Enzinger C, Berger T; AUT-MuSC-19 investigators. Bsteh G, et al. Among authors: wipfler p. Eur J Neurol. 2022 Jun 25:10.1111/ene.15477. doi: 10.1111/ene.15477. Online ahead of print. Eur J Neurol. 2022. PMID: 35751475 Free PMC article.
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study.
Moser T, O'Sullivan C, Otto F, Hitzl W, Pilz G, Schwenker K, Mrazek C, Haschke-Becher E, Trinka E, Wipfler P, Harrer A. Moser T, et al. Among authors: wipfler p. Ther Adv Neurol Disord. 2022 Apr 22;15:17562864221092092. doi: 10.1177/17562864221092092. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35479655 Free PMC article.
35 results